Another satisfied customer.........
================
Wednesday December 5, 7:45 am Eastern Time
Press Release
SOURCE: Hypertension Diagnostics, Inc.
Hypertension Diagnostics Provides Additional HDI/PulseWave(TM) CR-2000 Profiling Systems to Pfizer, Inc. for Major Study
ST. PAUL, Minn., Dec. 5 /PRNewswire/ --
Hypertension Diagnostics, Inc. (Nasdaq: HDII - news) announced today that Pfizer Pharmaceuticals Group, a division of Pfizer, Inc. (NYSE: PFE - news), headquartered in New York City, has purchased additional units of HDI's non-invasive HDI/PulseWave(TM) CR-2000 Research CardioVascular Profiling System for use in a previously announced multi-center cardiovascular drug research trial. Greg H. Guettler, President of HDI, said, "We are very pleased that Pfizer has expanded the scope of its research trial and that HDI is a key component of that expansion."
(abridged)
biz.yahoo.com
================
In addition to this obviously good news, there are some new factors in this press release: 1. The press release came out at 7:45 AM, not at 2:00 AM as the company had previously done. This will more directly alert analysts and investors just when they’re coming online to evaluate premarket news. 2. More importantly, the news release has already appeared on PRNewswire AND Dow Jones News Service. I don’t recall seeing the company’s news releases on Dow Jones in the past (and the press release may be appearing on other services as well…which I believe is also a change).
These changes indicate the company is making the moves necessary to properly and adequately publicize their progress.
These are extremely welcome and extremely positive changes and clearly show the company understands the variety of explicit and subtle adaptations that are required to become a major player in the medical device field. |
